XML 29 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive Income (loss)
Non- controlling interests
Treasury shares
Total
Balance at Dec. 31, 2021 $ 88,849   $ 241,946,362 $ 1,230,511 $ (122,498,259) $ 2,489,017 $ 7,593,014 $ (4,066,610) $ 140,884,573
Balance (in Shares) at Dec. 31, 2021 88,849,222 14,101,689           (144,206)  
Net loss   (9,448,446) (1,879,365) (11,327,811)
Share-based compensation for employee and director stock awards   64,193 64,193
Common stock issued to employees and directors for stock award $ 286   (286)
Common stock issued to employees and directors for stock award (in Shares) 285,842            
Capital injection   1,148,447 338,232 1,486,679
Disposal of partial interest in a subsidiary without losing control   3,082,282 1,377,756 4,460,038
Foreign currency translation adjustment   (10,642,661) (546,514) (11,189,175)
Balance at Dec. 31, 2022 $ 89,135   246,240,998 1,230,511 (131,946,705) (8,153,644) 6,883,123 $ (4,066,610) $ 124,378,497
Balance (in Shares) at Dec. 31, 2022 89,135,064 14,101,689           (144,206) 88,990,858
Net loss   (2,449,057) (6,090,270) $ (8,539,327)
Share-based compensation for employee and director stock awards   1,225,747 1,225,747
Common stock issued to employees and directors for stock award $ 928   (928)
Common stock issued to employees and directors for stock award (in Shares) 928,332            
Foreign currency translation adjustment   (3,447,759) (158,817) (3,606,576)
Balance at Dec. 31, 2023 $ 90,063   $ 247,465,817 $ 1,230,511 $ (134,395,762) $ (11,601,403) $ 634,036 $ (4,066,610) $ 113,458,341
Balance (in Shares) at Dec. 31, 2023 90,063,396 14,101,689           (144,206) 89,919,190